14-day Premium Trial Subscription Try For FreeTry Free
Neogen's (NEOG) robust segmental performance and notable product launches instill investors' confidence.
Neogen's (NEOG) newest addition to the biosecurity portfolio is anticipated to curb the spread of diseases like COVID-19 and avian influenza.
NEOGEN's (NEOG) insect control solution for poultry producers is the latest addition to the company's Prozap product line.
NEOGEN's (NEOG) recent launch enables simultaneous low-pass whole genome sequencing and high-coverage genotyping at regions of interest.
NEOGEN's (NEOG) latest Prozap Protectus Pour-On Insecticide- IGR product relieves cattle from infestations.

Neogen's (NEOG) Q3 Earnings Miss Estimates, Margins Down

04:54pm, Friday, 25'th Mar 2022 Zacks Investment Research
Robust segmental performance and contributions from the Soleris product line drive the top line for Neogen (NEOG) in third-quarter of fiscal 2022 results.
Robust segmental performance and contributions from the Soleris product line drive the top line for Neogen (NEOG) in third-quarter of fiscal 2022 results.

Company News for Mar 25, 2022

01:54pm, Friday, 25'th Mar 2022 Zacks Investment Research
Companies in The News Are: MOMO,NEOG,OLLI,KBH

Neogen (NEOG) Q3 2022 Earnings Call Transcript

09:00pm, Thursday, 24'th Mar 2022 The Motley Fool
NEOG earnings call for the period ending December 31, 2021.
Neogen Corporation. (NEOG) CEO John Adent on Q3 2021 Results - Earnings Call Transcript

Neogen (NEOG) Misses Q3 Earnings and Revenue Estimates

02:05pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Neogen (NEOG) delivered earnings and revenue surprises of -13.33% and 1.35%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Neogen Shares Are Falling

01:39pm, Thursday, 24'th Mar 2022
Neogen Corporation (NASDAQ: NEOG) shares are trading lower by 9.6% at $30.51 after the company reported worse-than-expected third-quarter EPS and sales results. Neogen reported quarterly earnings of 1
Neogen Corporation's (NASDAQ: NEOG) Q3 FY22 sales increased 9.9% Y/Y to $128.2 million, missing the consensus of $129.99 million. Food Safety segment revenue reached $62.7 million, +7% (+4% on an or

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates

09:25pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Exagen Inc. (XGN) delivered earnings and revenue surprises of 14.29% and 9.86%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Hold Onto Neogen (NEOG) Stock for Now

06:57pm, Friday, 11'th Mar 2022 Zacks Investment Research
Investors are optimistic about Neogen's (NEOG) progress at the Food Safety and Animal Safety segments.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE